Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

ClinicalTrials.gov ID: NCT04592874

Public ClinicalTrials.gov record NCT04592874. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 25, 2026, 2:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A phase 2 randomized, double blind, placebo controlled study evaluating the efficacy and safety of AL002 in participants with Early Alzheimer's Disease.

Study identification

NCT ID
NCT04592874
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alector Inc.
Industry
Enrollment
356 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 21, 2021
Primary completion
Aug 18, 2024
Completion
Sep 11, 2024
Last update posted
Oct 28, 2025

2021 – 2024

United States locations

U.S. sites
29
U.S. states
16
U.S. cities
28
Facility City State ZIP Site status
Banner Alzheimer's Institute Phoenix Arizona 85006 —
Woodlands Research Network, LLC - ERG Rogers Arkansas 72758 —
ATP Clinical Research Costa Mesa California 92626 —
Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
South Florida Neurology Associates Boca Raton Florida 33487 —
Brain Matters Research - ERG Delray Beach Florida 33445 —
Charter Research Lady Lake Florida 32159 —
ClinCloud, LLC Maitland Florida 32751 —
K2 Medical Research Maitland Florida 32751 —
K2 Winter Garden Ocoee Ocoee Florida 34761 —
Progressive Medical Research Port Orange Florida 32127-5170 —
Axiom Clinical Research FL Tampa Florida 33609 —
K2 The Villages The Villages Florida 32159 —
Alzheimers Research and Treatment Center Wellington Florida 33449 —
Conquest Clinical Research (Winter Park) Winter Park Florida 32789 —
Emory University Atlanta Georgia 30322 —
AMITA Health Clinical Research Institute Elk Grove Village Illinois 60007 —
University of Kentucky Lexington Kentucky 40536 —
Boston Center for Memory Newton Massachusetts 02459 —
Hattiesburg Clinic Hattiesburg Mississippi 39401 —
Advanced Clinical Institute Neptune City New Jersey 07753 —
Feinstein Institute For MR Manhasset New York 11030 —
Columbia University College of Physicians and Surgeons New York New York 10032-3725 —
University of Rochester Medical Center Rochester New York 14620 —
SUNY Upstate Medical Center Syracuse New York 13210 —
University of Cincinnati MC Cincinnati Ohio 45219 —
Summit Research Network Portland Oregon 97210 —
Abington Neurologic Associates Abington Pennsylvania 19090 —
Clinical Trial Network Houston Texas 77074-2085 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04592874, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2025 · Synced Sep 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04592874 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →